Categories AlphaGraphs, Earnings, Health Care
Key highlights from Biogen’s (BIIB) Q3 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today.
Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were down 3% on a constant currency basis as well.
Net income attributable to Biogen Inc. was $388.5 million, or $2.66 per share, compared to a loss of $68.1 million, or $0.47 per share, last year. Adjusted EPS decreased 6% to $4.08.
For the full year of 2024, Biogen expects total revenue to decline by a low-single-digit percentage compared to the previous year. Adjusted EPS is expected to be $16.10-16.60.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key highlights from Hewlett Packard Enterprise’s (HPE) Q1 2025 earnings results
Hewlett Packard Enterprise (NYSE: HPE) reported its first quarter 2025 earnings results today. Revenue was $7.9 billion, up 16% year-over-year and 17% in constant currency. Net earnings attributable to common
AVGO Infographic: Broadcom Q1 2025 revenue and earnings beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenue and adjusted earnings for the first quarter of 2025. The numbers also surpassed Wall Street's expectations. Earnings, excluding special items, increased
Macy’s (M) Q4 2024 Earnings: Key financials and quarterly highlights
Macy’s Inc. (NYSE: M) reported its fourth quarter 2024 earnings results today. Net sales decreased 4.3% year-over-year to $7.8 billion. Comparable sales were down 1.1% on an owned basis and
